The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
about
A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteinsEpigenetic regulation of CpG promoter methylation in invasive prostate cancer cellsCancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?TWIST1 and BMI1 in Cancer Metastasis and ChemoresistanceBioengineering Models for Breast Cancer ResearchThe molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targetsAutophagy in stem cells.Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaCancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaRacial disparity in colorectal cancer: Gut microbiome and cancer stem cellsEpithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connectionThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisThe Regulatory Role of MicroRNAs in EMT and CancerDoxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse modelsWithaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cellsEpithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cellsCancer stem cells and their mechanism of chemo-radiation resistanceEpithelial to mesenchymal transition and breast cancer.Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma.Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells.Matrix metalloproteinase 1 and circulating tumor cells in early breast cancerStemness is Derived from Thyroid Cancer Cells.ErbB/EGF signaling and EMT in mammary development and breast cancer.Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.Increase of α-SMA(+) and CK (+) cells as an early sign of epithelial-mesenchymal transition during colorectal carcinogenesis.Role of Cripto-1 in stem cell maintenance and malignant progression.Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancerTargeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.Expression patterns of Thymosin β4 and cancer stem cell marker CD133 in ovarian cancers.Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell linesTranscription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheresFas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristicsInflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transitionCancer stem cells and side population cells in breast cancer and metastasis.Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells
P2860
Q21267208-0A83041D-E0F3-4891-93D2-0921C3D88B42Q24302022-B3D7562B-2451-4DD8-A8E2-0C4BFCC2F2E0Q24628819-C347A5B7-AD2E-4E54-AC29-B198FEE0D4DEQ26744196-8534D63C-F86E-4E20-8729-38A8D8EB8D0BQ26770495-64A0664F-2FE3-4257-8C92-A53A055B905AQ26782593-92EC95AC-04F9-4460-97CD-AD8610E52155Q26823995-21C0D46A-8E35-48D7-B4B4-0159BA7704BEQ26849546-6358F5C1-29B1-404D-ADF3-7AFCE073F08FQ26998068-2DE039BC-045C-4A22-A442-BB7DD52D9F93Q28075465-5FE44D64-F703-470D-B7B4-6CC9CC38052BQ28248085-E53E82D2-0B90-42BE-BCD9-4A215C5A9209Q28388257-AD554E7F-DBDA-4679-845E-AB644D895A94Q28391426-18990DA7-3B8F-4C71-8715-026BA2229E85Q28473783-30DFDFFE-C2F3-4CE4-B822-DFA853AE0F0DQ28543359-2D7DC390-7CF9-44EE-AAB4-7150779BB6E1Q30988612-CA934917-5628-4864-8030-612F200C9880Q33614696-F0EC0FE2-14B9-49D4-95B1-1F442B2B3D40Q33627118-BC268967-6BC0-4CD0-8CBA-65F10750147EQ33793359-1C953B74-A52C-4B03-89A7-9ECEB27C7EF2Q33795345-E0BC1F90-FBE3-4F15-87DE-ED0005B4336AQ33839166-84954BCD-EE52-4F24-BAA4-F680DB8B9623Q33901058-946B8F85-D75D-425A-BCF6-6C09D6FFF719Q33927493-7EEE7EE4-FED2-446D-9018-6BE4E635D1C9Q33945493-0F12DBB1-27B5-4F74-8689-4E7AD4C56DA9Q34018064-55183E68-E914-4283-BA7E-7091774798E2Q34033323-BBD70E01-145F-410D-8233-68746FFDB1BBQ34077272-166873E8-596B-44C5-BFE5-1B8F44EEB1CCQ34136905-1E180FE2-BFF7-4BD0-A83E-2E8C62AB8AB6Q34168398-F09D255B-0BF8-421D-9542-6551934BD638Q34208986-C5E3BE93-16DD-40DC-91B1-57DD4CEBB533Q34274752-CE94BCFE-CE15-4496-9226-ACFC45A2E3A2Q34440409-AA36F36B-F2A0-4AF8-98B4-369D9BC6DE01Q34461440-B3E086D1-87D8-40B0-B569-BAB1275B7723Q34583510-273F12B4-C4F6-4BF6-902C-3E7231EA737EQ34765897-D5F199FD-7058-40D0-910C-F5D7AAECD153Q34786557-F7E05EFF-D089-4AD8-8DA7-D7BAEC636CCDQ34868601-766500CD-7366-43EF-80CC-EB416B13C7D1Q34984217-589529EC-0011-49F9-91FD-8C99E7ED6D1DQ35038054-DE225828-3AA0-4798-8EE5-BD35578D623EQ35091219-04478380-D599-4D8A-9B24-57438C9F46DA
P2860
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@en
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@nl
type
label
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@en
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@nl
prefLabel
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@en
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@nl
P1476
The epithelial-to-mesenchymal ...... tion against cancer therapies.
@en
P2093
Brett G Hollier
Kurt Evans
P2860
P2888
P356
10.1007/S10911-009-9110-3
P577
2009-02-26T00:00:00Z